Currently submitted to: JMIR Rehabilitation and Assistive Technologies
Date Submitted: Oct 24, 2025
Open Peer Review Period: Nov 5, 2025 - Dec 31, 2025
(closed for review but you can still tweet)
NOTE: This is an unreviewed Preprint
Warning: This is a unreviewed preprint (What is a preprint?). Readers are warned that the document has not been peer-reviewed by expert/patient reviewers or an academic editor, may contain misleading claims, and is likely to undergo changes before final publication, if accepted, or may have been rejected/withdrawn (a note "no longer under consideration" will appear above).
Peer review me: Readers with interest and expertise are encouraged to sign up as peer-reviewer, if the paper is within an open peer-review period (in this case, a "Peer Review Me" button to sign up as reviewer is displayed above). All preprints currently open for review are listed here. Outside of the formal open peer-review period we encourage you to tweet about the preprint.
Citation: Please cite this preprint only for review purposes or for grant applications and CVs (if you are the author).
Final version: If our system detects a final peer-reviewed "version of record" (VoR) published in any journal, a link to that VoR will appear below. Readers are then encourage to cite the VoR instead of this preprint.
Settings: If you are the author, you can login and change the preprint display settings, but the preprint URL/DOI is supposed to be stable and citable, so it should not be removed once posted.
Submit: To post your own preprint, simply submit to any JMIR journal, and choose the appropriate settings to expose your submitted version as preprint.
Warning: This is an author submission that is not peer-reviewed or edited. Preprints - unless they show as "accepted" - should not be relied on to guide clinical practice or health-related behavior and should not be reported in news media as established information.
Usability and Functional Outcomes of the Obi3 Robotic Feeding Device: A Mixed-Methods Study Among Patients, Caregivers, and Providers
ABSTRACT
Background:
Loss of self-feeding ability due to severe upper extremity motor impairment (UEMI) limits independence, compromises nutrition, and reduces social participation. Robotic feeding devices are an emerging category of assistive technology. Obi3 is a 3rd generation, Class I durable medical equipment (DME) robot intended to compensate for the movement of a human arm to restore self-feeding performance. The device is designed to enable patients to independently select and consume food and liquid using accessible switches or interfaces while maintaining culturally normative dining practices. Although earlier Obi generations showed promise, comprehensive usability data across multiple stakeholder groups remains limited.
Objective:
This study evaluated the usability, safety, and clinical relevance of Obi3 from the perspectives of patients, caregivers, and rehabilitation providers in real-world use. The findings were intended to generate evidence that informs clinical decision-making and determinations of medical necessity for DME consistent with the device’s FDA-cleared Indications for Use and clinician-supervised implementation.
Methods:
A mixed-methods usability study enrolled 50 participants, of whom 42 completed follow-up surveys after a one-week home trial of Obi3. Participants included 15 patients (pediatric and adult), 14 caregivers, and 13 providers. Quantitative measures included the System Usability Scale (SUS), survey items adapted from the Matching Person and Technology (MPT) framework, and self-feeding impairment ratings based on the International Classification of Functioning, Disability and Health (ICF). Paired-sample t tests, Wilcoxon signed-rank tests, and effect sizes (Cohen d) assessed changes in self-feeding scores. Qualitative data from open-ended survey responses and follow-up semi-structured interviews underwent thematic content analysis to complement quantitative findings.
Results:
Patients’ mean self-feeding impairment scores decreased significantly from 3.80 (SD 0.41) at baseline to 0.60 (SD 0.74) posttrial (n = 15; t₍₁₄₎ = 10.75, P < .001; Cohen d = 3.40). All patient participants demonstrated improvement in functional self-feeding ability. Mean SUS scores exceeded the benchmark for acceptable usability (≥68) across stakeholder groups: patients, 82.8 (SD 17.2); caregivers, 85.2 (SD 12.6); and providers, 85.0 (SD 10.7). Responses to Matching Person and Technology (MPT) items indicated strong alignment between user goals and device capabilities, perceived safety, and low complexity. Caregivers reported reduced feeding-related workload and stress, and providers endorsed ease of clinical integration. No adverse events or device malfunctions occurred.
Conclusions:
Obi3 demonstrated high usability, safety, and clinical utility in restoring self-feeding independence among individuals with severe UEMI. Findings across patients, caregivers, and providers support Obi3 as an effective piece of DME that enhances user autonomy and reduces caregiver burden. Future multisite and longitudinal research is warranted to confirm long-term outcomes, maintenance, and integration into rehabilitation practice. Clinical Trial: The study was approved by WCG IRB (protocol #20251472), and all participants provided informed consent.
Citation
Request queued. Please wait while the file is being generated. It may take some time.
Copyright
© The authors. All rights reserved. This is a privileged document currently under peer-review/community review (or an accepted/rejected manuscript). Authors have provided JMIR Publications with an exclusive license to publish this preprint on it's website for review and ahead-of-print citation purposes only. While the final peer-reviewed paper may be licensed under a cc-by license on publication, at this stage authors and publisher expressively prohibit redistribution of this draft paper other than for review purposes.